loe 908 has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christensen, T; Diemer, NH; Ensinger, HA; Wienrich, M | 1 |
| Carano, RA; Fisher, M; Irie, K; Li, F; Pschorni, U; Silva, MD; Sotak, CH; Tatlisumak, T | 1 |
2 other study(ies) available for loe 908 and Disease Models, Animal
| Article | Year |
|---|---|
The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.
Topics: Acetamides; Animals; Astrocytes; Blood Pressure; Body Temperature; Brain Infarction; Disease Models, Animal; Hematoxylin; Immunohistochemistry; Infusions, Intravenous; Isoquinolines; Male; Neuroglia; Rats; Rats, Wistar; Survival | 2005 |
Neuroprotective effects of a novel broad-spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: a multispectral study.
Topics: Acetamides; Animals; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Ion Channels; Ischemic Attack, Transient; Isoquinolines; Least-Squares Analysis; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Time Factors | 1999 |